I'm not 100% sure....
But people seem to think Albert Einstein crowned compound interest as the 8th wonder of the world.
And although I doubt that's what the ol' genius concerned himself with...
Compound interest is arguably the most broken investing hack we've seen.
You'll never really understand what can happen in 10 years until you watch your money accumulate in that time.
And I can't think of a better way to see this in action than through investing in dividend stocks.
Picking the right stocks automatically puts you in a position to reap a lot more than you've sown overtime.
But one wrong stock, and it's game over for your entire portfolio.
That's why I've been trying to get the 5 Dividend Investing Cheat Sheets into your hands…
In there, you'll see every single thing I'd consider before I even touch any stock for dividends.
You'll also see the 2 stocks I'm pouring $50,000 of my own money into.
Of course I can't make absolute guarantees here...
But your best bet is to grab the 5 Dividend Investing Cheat Sheets and look through it before throwing money at any stock.
Better yet, go here and get it now while it's still available at no cost.
By clicking the link above you agree to periodic updates from ProsperityPub and its partners (privacy policy)
ALHC Stock Surges 400%—Here's Why the Bulls Aren't Done
Reported by Chris Markoch. Article Posted: 1/26/2026.
Article Highlights
- Alignment Healthcare stock is up more than 400% since April 2024, as improving Medicare Advantage cost trends and disciplined growth have driven a fundamental re-rating.
- ALHC’s value-based care model positions the company to benefit from a Medicare rebound as hospital economics stabilize and utilization normalizes into 2026.
- While ALHC stock remains technically overextended, the bullish trend is intact, with pullbacks toward key support levels offering favorable risk-reward entries.
Alignment Healthcare Inc. (NASDAQ: ALHC) is an example of why even buy-and-hold investors should leave room for nimble movement. ALHC stock is up more than 58% in the last 12 months and more than 415% since April 2024.
In April, the stock traded around $4.50 per share and could have been classified as a penny stock.
NEW LAW: Congress Approves Setup For Digital Dollar? (Ad)
Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0
But according to Rep. Marjorie Taylor Green, it's a bill that contains "the entire setup, groundwork and infrastructure to move from cash to digital currency."
Many investors may have anticipated the move because Alignment Healthcare operates in Medicare Advantage and focuses on value-based care. The company's integrated model combines in-home clinical services, telehealth capabilities, and digital health tools.
Over the past two years, health insurance stocks—particularly those tied to Medicare Advantage—have posted strong gains, benefiting from scale, pricing power, and a growing senior population.
The Broader Healthcare Trend Is Turning
According to The Wall Street Journal, beaten-down hospital stocks are expected to rally as cost inflation eases, staffing conditions improve, and reimbursement rates begin to stabilize. As these headwinds recede, investor sentiment toward the broader healthcare services ecosystem should improve, including companies tied to Medicare utilization and senior care.
That outlook helps explain why investors can still be bullish on ALHC stock. The company's 18-month rally marks a fundamental reset in how investors view the company's business model.
Medicare Advantage insurers faced a difficult stretch in 2023 and early 2024, driven by higher medical costs and reimbursement uncertainty. Alignment, however, began demonstrating tangible progress in controlling expenses: medical cost trends improved, risk-adjustment capture strengthened, and management shifted toward more-disciplined growth.
That efficiency appears to have convinced investors that Alignment's value-based care strategy can scale profitably. Equally important, the period of weakness gave investors leveraged exposure to a potential Medicare rebound when much of the bad news was already priced in.
As fears around margin compression have faded, the stock has benefited from both a fundamental re-rating and technical tailwinds, including short covering and renewed interest in mid-cap healthcare names. If hospital economics and Medicare utilization continue normalizing in 2026, Alignment's integrated care model and mid-cap positioning could make the company a meaningful beneficiary of improving industry conditions.
ALHC Stock Looks Overbought, But the Uptrend Is Intact
For all the reasons investors might buy ALHC stock, now might not be the best entry. ALHC is technically extended: the price is pushing to new 52‑week highs and trading well above key moving averages, signaling a strong but stretched uptrend.
The daily RSI in the low‑70s and a strongly positive MACD reflect overbought momentum rather than a low‑risk entry, so chasing at current levels offers poor risk‑reward even though the trend remains bullish.
A better approach for investors on the sidelines is to stay constructive on the name but wait for a pullback into support. The first buy zone is around $21.50 to $22 — an area of recent consolidation just below the highs where an initial bounce would favor more aggressive entries.
A more conservative, higher‑probability zone sits around $20.25–$20.75, near the rising 50‑day moving average and the prior base. If the stock can hold these levels, it would confirm trend integrity. Traders could scale in at the upper zone and add closer to the 50‑day, then use a stop just below the 20‑day SMA to define risk, while targeting a retest and modest extension into the $24–$25 range, provided pullbacks remain orderly and support holds.
This email message is a sponsored message from ProsperityPub, a third-party advertiser of MarketBeat. Why was I sent this email content?.
If you have questions about your account, please contact MarketBeat's U.S. based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2026 MarketBeat Media, LLC. All rights protected.
345 N Reid Place, Suite 620, Sioux Falls, South Dakota 57103. United States of America..
Post a Comment
Post a Comment